JW Lifescience Corporation (KRX:234080)
13,150
-70 (-0.53%)
Mar 13, 2026, 1:10 PM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 204.71 billion as of March 12, 2026. Its market cap has increased by 27.12% in one year.
Market Cap
204.71B
Enterprise Value
227.76B
Revenue
248.30B
Ranking
n/a
PE Ratio
4.30
Stock Price
13,150.00
Market Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 204.71B, a decrease of -39.80%. That is a compound annual growth rate of -5.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 204.71B | 2.88% |
| Dec 30, 2025 | 198.98B | 18.11% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chong Kun Dang Holdings | 228.27B |
| Suheung | 227.39B |
| Daewon Pharmaceutical | 219.05B |
| Samil Pharmaceutical Co.,Ltd | 213.78B |
| Samjin Pharmaceuticals | 213.04B |
| HLB Pharmaceutical | 212.88B |
| Jeil Pharmaceutical Co.,Ltd | 200.07B |
| AptaBio Therapeutics | 193.84B |